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 Figure S1. Biotinylation of the biligand for the dot blot. 
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Figure S2. Typical sorting process with COPAS Plus by optimizing gating and sorting 
region. a) First sorting is accomplished by accepting right side of ab  to eliminate 
broken beads and above bc  to collect only beads associated with the dye labeled 
protein. The results show that uniformly-sized beads with high red fluorescence are 
pre-selected for the second sorting.  b) The second sorting is accomplished by selecting 
the region above the line de  (combination of high red fluorescence and uniform size by 
running BioSort software (Union Biometrica)) for beads with higher red fluorescence. 
Typically 50 - 100 beads (0.015 - 0.03 % hit rate) were sorted by the COPAS instrument, 
starting from 200 mg (ca. 300 000 beads).    
 
Figure S3. MS spectra of peptides that are not correctly sequenced using standard peak 
selection algorithms.   a) linppm* (m* = homoserine lactone)  (entry 41, Table S1) 
features a prominent peak that arises from a Na
+
 adduct to the parent ion.   b) gnfetm* 
(m* = homoserine lactone) (entry 42, Table S1) exhibits a feature that arises from 
ionization of matrix material, which is very close to the parent mass peak (+6 amu) (* = 
adventitious peaks from the matrix). 
 
 
Figure S4. Removal of sodium adducts by washing sample spots on MALDI plate with 10 mM ammonium monobasic 































































































































































































Figure S5. Cyclization of N-terminal amino acids. a) Formation of pyroglutamate from glutamic acid in efrrkm*. b) Formation 
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Figure S6. Fragments of rrrrm* (m* = homoserine lactone) in the low mass range (0 – 
160). Low mass peaks from R (arginine) are 60, 70, 87, 88, 95, 112, 115, 129, 139, 140 
and 157. 
 
Figure S7. Fragments of rkkkkm* (m* = homoserine lactone) in the low mass range (0 – 




Figure S8. Fragments of wwwwm* (m* = homoserine lactone) in the low mass range (0 
– 160). Low mass peaks from W (tryptophan) are 130 and 159.  
 
Figure S9. Examples of sequencing peptides that contain isobaric amino acids. 
Sequencing of a) (l/i)(k/q)h(k/q)rfm* and b) ighkrfm* (m* = homoserine lactone). 
I/LQ/KHQ/KRF
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Figure S10. SPR response sensograms for the biligand capture agents (concentration of biligands varied from 2 nM to 5 μM).  
Kinetic analysis by Biacore T100 Evaluation software (version 2.0.1, Biacore). 

































































ifvykr-lhrywf klfvrl-lhrywf Caltech biligand*
Kinetics (2 state model) 1.7 1.3 1.4












































*  Agnew, H.D.; Rohde, R.D.; Millward S.W.; Nag, A.; Yeo, W.-S.; Hein, J.E.; Pitram S.M.; Tariq, A.A.; Burns, V.M.; Krom, R.J. Fokin, V.V.; 
Sharpless, K.B.; Heath, J.R.  “Iterative in situ Click Chemistry Creates Antibody-like Protein Capture Agents”  Angew. Chem. Int. Ed. 2009, 
48, 1-5. 
Figure S11. Increase of the 70 amu mass peak featured in the presence of r or p in a peptide. (m* = homoserine lactone) 































































































































































































































Table S1.  Other considerations for improvement of the sequencing algorithm (m* = 
homoserine lactone). 
Manual checking points Examples 
b, y and a ions  
Loss of ammonia from R, K, W, Q, N 
R shows much clear loss of ammonia 
AYRSYM* → b ions: AYR – 17, AYRS – 17, 
AYRSY – 17 and AYRSYM* – 17; y ions: RSYM* 
– 17, YRSYM* – 17 and AYRSYM* – 17 
Internal cleavage at P or H 
MS/MS spectrum of WLHAGM* contains 
fragmented ion peaks from HAGM* in addition 
to those from WLHAGM*. 
Relative intensity of low mass peaks 
For cases in which p and r existed in the same 
sequence, the intensity of a 60 amu mass peak 
noticeably increased by 50 – 150%. 
(Supporting Information, Figure S11) 
 
 
















1 706 hlkllm* PEAKS 706 hlkii m  
2 713 nptwlm* PEAKS 713 nptwim  
3 628 lvgrtm* PEAKS 628 lvgrtm  
4 743 frklpm* PEAKS 743 frkipm  
5 711 hlvlfm* PEAKS 711 hlvlfm  
6 742 nwralm* PEAKS 742 nwraim  
7 696 htlrsm* PEAKS 696 htirsm  
8 782 fwphlm* PEAKS 782 fwphim  
9 610 gtvnhm* PEAKS 610 gtvnhm  
10 752 wfestm* PEAKS 752 wfestm  
11 671 altfhm* PEAKS 671 altfhm  
12 914 hrwwfm* PEAKS 914 hrwwfm  
13 821 wnyqqm* PEAKS 821 wnyqkm  
14 783 rdhwsm* PEAKS 783 rdhwsm  
15 784 nwlrlm* PEAKS 784 nwirlm  
16 733 plqhrm* PEAKS 733 pikhrm  
17 718 lynllm* PEAKS 718 lyniim  
18 693 yvnqsm* PEAKS 693 yvnksm  
19 807 rekeym* PEAKS 807 rekeym  
20 750 nfnwsm* PEAKS 750 nfnwsm  
21 799 lykrhm* PEAKS 799 iykrhm  
22 676 qavylm* Semi-auto 676 kavyim  
23 644 wldagm* Semi-auto 644 wldagm  
24 743 drqnqm* Semi-auto 743 drqnkm  

















26 614 pktegm* Semi-auto 614 pqtegm  
27 821 lweykm* Semi-auto 821 lweykm  
28 672 lstrim* Semi-auto 672 lstrim  
29 873 hyewrm* Semi-auto 873 hyewrm From 
Edamn/MS 
clues 
30 612 tpklam* Semi-auto 612 tpklam  
31 676 gwadem* Semi-auto 676 gwadem  
32 640 pddpnm* Semi-auto 640 pddpnm  
33 720 klfddm* Semi-auto 720 kddlfm  
34 588 ktaegm* Semi-auto 588 getkam  
35 685 tnrvlm* Semi-auto 685 trnvlm  
36 655 lvrgkm* Semi-auto 655 ivrkgm  
37 675 tlflvm* Semi-auto 675 vdfivm  
38 619 hsfhvm* PEAKS 597 hsltgm OM – CM = 
22 
39 665 nakysm* PEAKS 643 naqvem OM – CM = 
22 
40 616   594 pikpgm OM – CM = 
22 
41 658 srpesm* PEAKS 636 linppm OM – CM = 
22 
42 672   650 gnfetm OM – CM = 
22 
43 694 ktphem* PEAKS 672 tqppfm OM – CM = 
22 
44 750 vllhwm* Semi-auto 712 vilvwm  
45 No peak   689 gnewtm  
46 No peak   804 ewsnwm  
47 No peak   591 glkdgm  
48 No peak   555 vgsipm  
 
Table S3. Sequencing of the halved beads from 28 randomly selected beads by MALDI-
TOF/TOF and Edman degradation. No differentiation of isobaric amino acids for MALDI-
TOF/TOF, i.e., k = q, l = i (m* = homoserine lactone). 
Sample m/z MALDI-TOF/TOF Edman degradation 
1 669.366 dvdhtm* dvdhtm 
2 696.316 Ysntem* ysntem 
3 
No observation of 
parent mass 
-  not clean 
4 679.4 lyetam* iyetam 
5 628.394 sktplm* kstpim 
6 666.361 wlhagm* wlhagm 
7 719.439 evlylm* evlyim 
8 766.425 arnhwm* arnhwm 
9 805.444 lytyym* iytyym 
10 755.462 wtprlm* wtprlm 
11 682.357 hegqem* hegqem 
12 802.444 wswlkm* wswikm 
13 723.427 ftlpym* ftlpym 
14 670.44 elravm* rleavm 
15 651.405 hnklgm* hnkigm 
16 615.42 akksvm* akksvm 
17 593.285 aphadm* aphadm 
18 787.318 efyvfm* fyevfm 
19 647.405 fnkvgm* fnkvgm 
20 718.375 hpwvpm* hpwvpm 
21 857.448 lwnwrm* iwwnrm 
22 742.373 ayrsym* ayrsym 
23 800.366 nnkwrm* nnkwrm 
24 718.363 wlgpym* wlgpym 
25 747.344 eswrsm* eswrsm 
26 804.399 hrfvym* hrfvym 
27 757.475 wrtvlm* wrtvim 
28 689.385 afrrgm* afrrgm 
Table S4.  Sequences of the hit beads from the screening of a focused hexamer library 
against bCAII (homoserine lactone at C-terminus). 
 
m/z Sequence 
972.551 k i y r f y 
1004.63 k i r y w r 
911.531 i q h k r f 
953.546 k y f k v w 
1045.558 y k r y w f 
1071.568 w r w r v w 
958.547 v k y r f y 
999.57 r r f q f y 
990.613 l h r y r y 
1036.54 w r w r y s 
1077.582 w r w y k r 
1032.6 l r w r y r 
983.605 l h r y r r 
989.57 y r w l r l 
1045.555 y r w k f y 
936.558 y l v f r r 
958.67 k i f r r r 
1049.634 r r w r r h 
1002.645 r l r r y r 
1013.546 l h r y w r 
1019.486 r q h w y f 
1051.677 k r w h w r 
1019.532 w r r y k k 
1000.53 r q w h y k 
867.584 k v l r r l 
1061.596 w r w r f k 
1014.625 w r w k k k 
875.559 r v y v q k 
955.619 l h r y r k 
1004.536 l h r y w f 
1013.523 l h r y w r 
1000.537 r k w h y q 
946.602 v w r f k k 
952.572 r y f k q k 
1022.599 w r w h v r 
955.559 l h r y r q 
1075.627 w r r y r r 
1008.604 r q r r f y 
  
m/z Sequence 
987.567 l r w h r h 
1000.569 l r y r f y 
1039.554 y l r y w r 
1004.494 l h r y w f 
940.547 l h r y l r 
1020.544 l h r y w y 
1013.672 l h r y w r 
962.526 w k q v y r 
1093.538 w r y h y w 
1135.553 w r y w r w 
1013.56 l h r y w r 
1000.474 w r h q y k 
985.51 l h r y k w 
1049.553 w r w k y k 
985.53 l h r y w k 
1005.538 y h r y k r 
985.596 w r w k k v 
938.565 l y i r y k 
985.56 l h r y w k 
990.528 y r y r i h 
1004.502 l h r y w f 
1012.63 r w i w r l 
Table S5. Sequences of hit beads from in situ screening of a comprehensive hexamer library (200 mg x 3, P* = 5-pentynoic 
acid, m* = homoserine lactone). 
Table S6. Sequences of hit beads form in situ screening of a focused hexamer library (200 mg x 2, P* = 5-pentynoic acid, m* 
= homoserine lactone). 
 
 
